Press Releases from Life Science Inkubator Bonn (1 total)
Life Science Inkubator (LSI) Bonn for the first time supports pharma industry sp …
- Merck spin-off Silvacx receives seed financing of almost EUR 2 million
Bonn, Germany, February 1, 2018 -- Life Science Inkubator GmbH (LSI) for the first time supports a research project originating from a pharma company. The project called Silvacx is a spin-off from Merck AG and is developing novel delivery technologies for cancer immunotherapy. The Silvacx team headed by Armin Kuebelbeck (previously Merck KGaA) also received public funding totaling EUR…